USA - February 18 2022
In 2021, approximately of all federal securities fraud class action lawsuits filed nationwide were against life sciences companies and their officers…
Douglas P. Baumstein, Emily Kanstroom Musgrave, Sean T. Prosser, James A. Rapore, Laurence A. Schoen, Adam L. Sisitsky, John F. Sylvia, Jason C. Vigna
USA - December 2 2020
Rule 30(b)(6) was overdue for an overhaul. It is too often the case that parties provide a list of generalized topics that cause discovery disputes…
USA - May 4 2020
As parties to merger or acquisition agreements carefully review their agreements to see what, if any, impacts the COVID-19 pandemic may have, the…
Joel D. Rothman, Alec Zadek
USA - December 1 2015
EB-5 regional centers and issuers take heed. The Securities and Exchange Commission ("SEC") is pursuing litigation against parties in several EB-5…
Douglas Hauer, Adam L. Sisitsky
USA - December 1 2015
While issuers and regional centers are the focus of EB-5 litigation right now and into the foreseeable future, if you are taking direct proceeds as a…
Douglas Hauer, Adam L. Sisitsky